Shopping Cart 0
Cart Subtotal
AED 0

Xiangxue Pharmaceutical Co Ltd (300147) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Xiangxue Pharmaceutical Co Ltd (XPH) is a pharmaceutical company that manufactures and distributes drugs and medicines. The company's products include drugs, Chinese medicine pieces, medical instruments, health products and medicinal drinks, among others. It also provides healthcare supplements, Chinese herbal medicine and pharmaceutical medicines, among others. XPH offers services such as industrial chain services, research and development services, procurement, manufacturing, delivering services and distribution services, among others. The company provides its products and services to healthcare and medical care sectors. It has its operations in Guangdong, Beijing, Shanxi, Sichuan, Chongqing, Anhui, Yunnan and Ningxia, China. XPH is headquartered in Guangzhou, China.

Xiangxue Pharmaceutical Co Ltd (300147)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Xiangxue Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Xiangxue Pharma Signs Agreement with GE Medical Systems Trade & Development 12

Xiangxue Pharma Plans to Form Joint Venture in Guangzhou City 13

Licensing Agreements 14

Xiangxue Pharma Enters into Licensing Agreement with Kinex Pharma for KX02 14

Equity Offering 16

Xiangxue Pharma Raises USD259 Million in Rights Offering of Shares 16

Debt Offering 17

Xiangxue Pharmaceutical Raises USD31.7 Million in Public Offering of Bonds 17

Xiangxue Pharma Raises USD75.6 Million in Public Offering of Bonds 18

Xiangxue Pharma Plans to Raise up to USD75.3 Million in Private Placement of Bonds Due 2022 19

Xiangxue Pharma Raises USD90.2 Million in Public Offering of Bonds 20

Xiangxue Pharma Plans to Raise up to USD188.5 Million in Public Offering of Bonds 21

Xiangxue Pharma Raises USD112 Million in First Tranche Public Offering of 3.39% Notes Due 2017 22

Xiangxue Pharma Announces Private Placement Of Bonds Due 2017 For USD 86.1 Million 23

Xiangxue Pharma Announces Public Offering Of Corporate Bonds For Up To USD 95.05 Million 24

Acquisition 25

Xiangxue Pharma Plans to Acquire Stake in a Biotechnology Firm for USD7.1 Million 25

Xiangxue Pharma to Acquire 60% Stake in Guangzhou Based Pharma Company 26

Xiangxue Pharma Plans to Acquire 55% Stake in Hubei Ji day Chinese Herbal Medicine for USD55 Million 27

Xiangxue Pharma To Acquire 70% Stake In China-Based Company For USD 73.7 Million 28

Xiangxue Pharma Plans To Acquire 25% Stake In China-Based Company For USD 0.03 Million 29

Xiangxue Pharma Acquires 52% Stake In China-Based Company For USD 4.1 Million 30

Xiangxue Pharma Plans To Acquire 7.98% Stake In China-Based Company For USD 2.4 Million 31

Xiangxue Pharmaceutical Co Ltd-Key Competitors 32

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 34

Other Significant Developments 34

Jun 07, 2018: GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35


List Of Figure

List of Figures

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Xiangxue Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Xiangxue Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Xiangxue Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Xiangxue Pharma Signs Agreement with GE Medical Systems Trade & Development 12

Xiangxue Pharma Plans to Form Joint Venture in Guangzhou City 13

Xiangxue Pharma Enters into Licensing Agreement with Kinex Pharma for KX02 14

Xiangxue Pharma Raises USD259 Million in Rights Offering of Shares 16

Xiangxue Pharmaceutical Raises USD31.7 Million in Public Offering of Bonds 17

Xiangxue Pharma Raises USD75.6 Million in Public Offering of Bonds 18

Xiangxue Pharma Plans to Raise up to USD75.3 Million in Private Placement of Bonds Due 2022 19

Xiangxue Pharma Raises USD90.2 Million in Public Offering of Bonds 20

Xiangxue Pharma Plans to Raise up to USD188.5 Million in Public Offering of Bonds 21

Xiangxue Pharma Raises USD112 Million in First Tranche Public Offering of 3.39% Notes Due 2017 22

Xiangxue Pharma Announces Private Placement Of Bonds Due 2017 For USD 86.1 Million 23

Xiangxue Pharma Announces Public Offering Of Corporate Bonds For Up To USD 95.05 Million 24

Xiangxue Pharma Plans to Acquire Stake in a Biotechnology Firm for USD7.1 Million 25

Xiangxue Pharma to Acquire 60% Stake in Guangzhou Based Pharma Company 26

Xiangxue Pharma Plans to Acquire 55% Stake in Hubei Ji day Chinese Herbal Medicine for USD55 Million 27

Xiangxue Pharma To Acquire 70% Stake In China-Based Company For USD 73.7 Million 28

Xiangxue Pharma Plans To Acquire 25% Stake In China-Based Company For USD 0.03 Million 29

Xiangxue Pharma Acquires 52% Stake In China-Based Company For USD 4.1 Million 30

Xiangxue Pharma Plans To Acquire 7.98% Stake In China-Based Company For USD 2.4 Million 31

Xiangxue Pharmaceutical Co Ltd, Key Competitors 32

Xiangxue Pharmaceutical Co Ltd, Subsidiaries 33

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Xiangxue Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Xiangxue Pharmaceutical Co Ltd (XPH) is a pharmaceutical company that manufactures and distributes drugs and medicines. The company's products include drugs, Chinese medicine pieces, medical instruments, health products and medicinal drinks, among others. It also provides healthcare supplements, Chinese herbal medicine and pharmaceutical medicines, among others. XPH offers services such as industrial chain services, research and development services, procurement, manufacturing, delivering services and distribution services, among others. The company provides its products and services to healthcare and medical care sectors. It has its operations in Guangdong, Beijing, Shanxi, Sichuan, Chongqing, Anhui, Yunnan and Ningxia, China. XPH is headquartered in Guangzhou, China.

Xiangxue Pharmaceutical Co Ltd (300147)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Xiangxue Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Xiangxue Pharma Signs Agreement with GE Medical Systems Trade & Development 12

Xiangxue Pharma Plans to Form Joint Venture in Guangzhou City 13

Licensing Agreements 14

Xiangxue Pharma Enters into Licensing Agreement with Kinex Pharma for KX02 14

Equity Offering 16

Xiangxue Pharma Raises USD259 Million in Rights Offering of Shares 16

Debt Offering 17

Xiangxue Pharmaceutical Raises USD31.7 Million in Public Offering of Bonds 17

Xiangxue Pharma Raises USD75.6 Million in Public Offering of Bonds 18

Xiangxue Pharma Plans to Raise up to USD75.3 Million in Private Placement of Bonds Due 2022 19

Xiangxue Pharma Raises USD90.2 Million in Public Offering of Bonds 20

Xiangxue Pharma Plans to Raise up to USD188.5 Million in Public Offering of Bonds 21

Xiangxue Pharma Raises USD112 Million in First Tranche Public Offering of 3.39% Notes Due 2017 22

Xiangxue Pharma Announces Private Placement Of Bonds Due 2017 For USD 86.1 Million 23

Xiangxue Pharma Announces Public Offering Of Corporate Bonds For Up To USD 95.05 Million 24

Acquisition 25

Xiangxue Pharma Plans to Acquire Stake in a Biotechnology Firm for USD7.1 Million 25

Xiangxue Pharma to Acquire 60% Stake in Guangzhou Based Pharma Company 26

Xiangxue Pharma Plans to Acquire 55% Stake in Hubei Ji day Chinese Herbal Medicine for USD55 Million 27

Xiangxue Pharma To Acquire 70% Stake In China-Based Company For USD 73.7 Million 28

Xiangxue Pharma Plans To Acquire 25% Stake In China-Based Company For USD 0.03 Million 29

Xiangxue Pharma Acquires 52% Stake In China-Based Company For USD 4.1 Million 30

Xiangxue Pharma Plans To Acquire 7.98% Stake In China-Based Company For USD 2.4 Million 31

Xiangxue Pharmaceutical Co Ltd-Key Competitors 32

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 34

Other Significant Developments 34

Jun 07, 2018: GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35


List Of Figure

List of Figures

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Xiangxue Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Xiangxue Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Xiangxue Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Xiangxue Pharma Signs Agreement with GE Medical Systems Trade & Development 12

Xiangxue Pharma Plans to Form Joint Venture in Guangzhou City 13

Xiangxue Pharma Enters into Licensing Agreement with Kinex Pharma for KX02 14

Xiangxue Pharma Raises USD259 Million in Rights Offering of Shares 16

Xiangxue Pharmaceutical Raises USD31.7 Million in Public Offering of Bonds 17

Xiangxue Pharma Raises USD75.6 Million in Public Offering of Bonds 18

Xiangxue Pharma Plans to Raise up to USD75.3 Million in Private Placement of Bonds Due 2022 19

Xiangxue Pharma Raises USD90.2 Million in Public Offering of Bonds 20

Xiangxue Pharma Plans to Raise up to USD188.5 Million in Public Offering of Bonds 21

Xiangxue Pharma Raises USD112 Million in First Tranche Public Offering of 3.39% Notes Due 2017 22

Xiangxue Pharma Announces Private Placement Of Bonds Due 2017 For USD 86.1 Million 23

Xiangxue Pharma Announces Public Offering Of Corporate Bonds For Up To USD 95.05 Million 24

Xiangxue Pharma Plans to Acquire Stake in a Biotechnology Firm for USD7.1 Million 25

Xiangxue Pharma to Acquire 60% Stake in Guangzhou Based Pharma Company 26

Xiangxue Pharma Plans to Acquire 55% Stake in Hubei Ji day Chinese Herbal Medicine for USD55 Million 27

Xiangxue Pharma To Acquire 70% Stake In China-Based Company For USD 73.7 Million 28

Xiangxue Pharma Plans To Acquire 25% Stake In China-Based Company For USD 0.03 Million 29

Xiangxue Pharma Acquires 52% Stake In China-Based Company For USD 4.1 Million 30

Xiangxue Pharma Plans To Acquire 7.98% Stake In China-Based Company For USD 2.4 Million 31

Xiangxue Pharmaceutical Co Ltd, Key Competitors 32

Xiangxue Pharmaceutical Co Ltd, Subsidiaries 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Xiangxue Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.